State Medicaid Drug Utilization Data for 2003

2003 data on covered outpatient drugs paid for by state Medicaid agencies under the Drug Rebate Program. The dataset includes state, drug name, National Drug Code, number of prescriptions, and dollars reimbursed. It is provided by the U.S. Department of Health & Human Services and was last updated on the platform in April 2026.

Use Cases

• Analyze state-level prescription volumes based on the number of prescriptions field.
• Model drug reimbursement costs based on the dollars reimbursed field.
• Track pharmaceutical utilization across jurisdictions based on the state and drug name fields.
• Study drug market share within Medicaid programs based on National Drug Code (NDC) identifiers.

Strengths

• Data is reported by states under a federal program (Medicaid Drug Rebate Program), suggesting a structured reporting process.
• Includes key financial and utilization metrics: dollars reimbursed and number of prescriptions.
• Provides drug identification via National Drug Code (NDC) for standardization.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Data may reflect geographic and temporal bias inherent to the 2003 Medicaid reporting scope.

Provenance

Source

U.S. Department of Health & Human Services

Collection Method

Reported by states for covered outpatient drugs paid for by state Medicaid agencies.

Time Range

2003

Freshness

Last updated 2026-04-08 20:28:30.685635; freshness should be verified.

Geography

United States (state-level)